NCT03747926View on ClinicalTrials.gov

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 5, 2019

Primary Completion Date

August 12, 2019

Study Completion Date

September 2, 2019

Conditions
Healthy
Interventions
DRUG

BI 705564

single-rising oral dose

DRUG

Placebo

single-rising oral dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03747926 - This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated | Biotech Hunter | Biotech Hunter